← Eichor
Study identifier: NCT06606717 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Resistance-band Training and Creatine and Whey Protein

Condition: Sarcopenia in Elderly  ·  Sponsor: University of Regina

PhaseNA
Planned participants36
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

The primary purpose of this research is to compare the effects of creatine monohydrate and/or whey protein supplementation during the first 10 weeks of a 20-week resistance-band training program on measures of body composition (whole-body lean tissue mass, total body water), arm and leg muscle thickness, upper- and lower-body muscle performance (i.e., strength, endurance) and functional ability (walking speed, balance). A secondary purpose of this research is to examine the effects of supplementation cessation (i.e., no creatine and/or whey protein supplementation) during the final 10 weeks of the 20-week resistance-band training program on these measures.

This description comes directly from the study's public registry record.

Talk to the study team

Darren Candow  ·  306-585-4906  ·  Darren.Candow@uregina.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of ReginaRegina, Saskatchewan, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06606717